Chief Science Officer, Alzheimer's Association
Appears in 1 story
Pushing for Medicare screening coverage as ASAP Act stalls
Alzheimer's diagnosis used to require a $5,000 brain scan or a painful spinal tap. As of August 2026, the FDA has cleared four blood tests for the disease, from Roche's Elecsys pTau217 to C2N's PrecivityAD2, approved for adults as young as 40.
Updated 3 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
